U.S. Patient Monitoring Systems Market by Component (Device Type, Service Type, and Connectivity Technology Type): Opportunity Analysis and Industry Forecast, 2020–2027

U.S. Patient Monitoring Systems Market Statistics 2027

The U.S. Patient Monitoring Systems Market was valued at $12,200.96 million in 2019, and is projected to reach $22,583.40 million by 2027, registering a CAGR of 5.21% from 2020 to 2027.

Patient monitoring systems are used to measure, record, distribute and display combinations of biometric values such as heart rate, blood oxygen saturation levels (SPO2), blood pressure, and temperature. They are used for monitoring patients regularly, which can help avoid serious problems. This reduces the number of emergency department visits, and duration of hospitalization. This is attributed to the large undiagnosed patient population, improving access to healthcare systems, and a high risk of developing chronic disease due to rapid urbanization. In addition, the increase in incidences of chronic diseases, such as diabetes and COPD, are responsible for the high growth rate. Furthermore, according to the IHS (Information Handling Services), more than four million patients are expected to monitor their health conditions remotely by 2020. This is a 34% increase in remote patient monitoring (RPM). Moreover, technological giants such as Google, Apple, and Amazon are tapping into the RPM market; which leads to drastic changes in healthcare.

 

Further, IoT applications in healthcare facilitate important tasks such as to improve patient outcomes, and also take some burden off health practitioners. Internet of Things (IoT)-enabled devices have made remote monitoring in the healthcare sector possible, unleashing the potential to keep patients safe and healthy, and empowering physicians to deliver superlative care. Furthermore, growth in IoT healthcare applications is indeed projected to accelerate as the Internet of Things is a key component in the digital transformation of the healthcare industry and various stakeholders are stepping up their effort in this field.

 

In addition, Patient monitoring devices are used to continuously measure or observe the physiological parameters of a patient. According to a study by Elliot and Coventry, it is important that the following eight parameters of a critically ill patient should be monitored: oxygen saturation, blood pressure, temperature, pain, pulse, level of consciousness, urine output, and respiration rate. All these parameters can be easily monitored with the help of various patient monitoring devices.

 

Though most of the markets are dropping down, COVID-19 outbreak has positively affected various healthcare related markets, one of them being patient monitoring systems. At present, the patient monitoring systems market is witnessing a tremendous growth. As these are playing a crucial role to combat the pandemic and monitor patients. Patient monitoring systems including cardiac monitors, respiratory devices and temperature monitoring devices are facing a huge demand, owing to their immense usage in patient treatment along with IoT technology. In addition, IoT, specifically and especially when combined with other transformative technologies such as Cloud and Artificial intelligence (AI). This led to wide range of applications of IoT in healthcare during this crisis.

 

The major factors that contribute toward the growth of the patient monitoring system market include increase in geriatric population, increased adoption of smart devices & wearable’s, and technological advancements. In addition, rising incidence rates of chronic diseases such as COPD, genetic diseases, respiratory diseases, and others also contribute toward uplifting growth of the patient monitoring systems market. Furthermore, collaborations between companies, hospitals, and academic institutions are expected to lead to the launch of new products, which would help to increase the market revenue and boost the market growth. However, data privacy & security issues and lack of awareness among public in developing country like U.S. Moreover, government regulations and reimbursement issues can also hamper growth of the U.S patient monitoring system market.

U.S. PATIENT MONITORING SYSTEM MARKET SEGMENTATION

The U.S. patient monitoring system market is segmented into a component which is further classified into device type is sub-segmented, service type and connectivity technology. By device type sub segmented hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices, fetal neonatal monitoring devices, respiratory monitors, multiparameter monitoring devices, remote patient monitoring devices, and temperature monitoring devices. The service type segment is further divided into consulting, foam dressings, system integration & deployment, and support & maintenance. The connectivity technology type segment is further categorized into cellular IoT, LoRa, NB-IoT, Wi-Fi, SIGFOX, wire line, wireless personal area network (WPAN), and others. Cellular IoT type is further subdivided into 3G and 4G.

 

 

On the basis component, the devices segment acquired largest market share in 2019, and is anticipated to maintain to forecast period. The cardiac monitoring devices segment dominated the patient monitoring devices market throughout the forecast period. This is attributed to rise in prevalence of various cardiovascular diseases such as congestive heart failure and stroke each year across the globe.

 

The report provides a comprehensive analysis of the key players operating in the U.S. patient monitoring system market, namely Apple Inc., Alphabet Inc. (Google), Abbott Laboratories, Boston Scientific Corporation, International Business Machine Corporation (IBM), General Electric Company, Johnson and Johnson, Nihon Kohden Corporation, Medtronic Plc, Masimo Corporation.

 

Other players in the patient monitoring system market include (Profiles not included in the report): - Cisco Systems Inc., Koninklijke Philips N.V., Microsoft Corporation, Schiller AG and among others.

KEY BENEFITS FOR STAKEHOLDERS

KEY MARKET SEGMENTS

1.1.Report description

1.2.Key benefits

1.3.Key market segments

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.CXO perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.3.Top Player Positioning

3.4.Porter’s five forces analysis

3.5.COVID-19 impact on the market

3.6.Government regulations

3.6.1.U.S. FDA

3.7.Reimbursement scenarios

3.8.Clinical trials

3.9.Patent analysis

3.9.1.Patents Registered/Approved, 2011–2020

3.9.2.Patents Registered/Approved, by Applicants, 2011–2020

3.9.3.U.S. patent analysis, by market applicants

3.10.Market Dynamics

3.10.1.Drivers

3.10.1.1.Rise in prevalence of lifestyle diseases

3.10.1.2.Increase in geriatric population

3.10.1.3.Rise in the adoption of remote patient monitoring devices

3.10.2.Restraints

3.10.2.1.Government regulations and reimbursement issues

3.10.2.2.Limited awareness and high costs

3.10.3.Opportunities

3.10.3.1.Technological advancements

4.1.Overview

4.1.1.Market size and forecast

4.2.Device

4.2.1.Market size and forecast

4.2.2.Hemodynamic monitoring devices

4.2.2.1.Key market trends and opportunity

4.2.2.2.Market size and forecast

4.2.3.Neuromonitoring devices

4.2.3.1.Key market trends and opportunities

4.2.3.2.Market size and forecast

4.2.4.Cardiac monitoring devices

4.2.4.1.Key market trends and opportunities

4.2.4.2.Market size and forecast

4.2.5.Fetal neonatal monitoring devices

4.2.5.1.Key market trends and opportunities

4.2.5.2.Market size and forecast

4.2.6.Respiratory monitors

4.2.6.1.Key market trends and opportunities

4.2.6.2.Market size and forecast

4.2.7.Multiparameter monitoring devices

4.2.7.1.Key market trends and opportunities

4.2.7.2.Market size and forecast

4.2.8.Remote patient monitoring devices

4.2.8.1.Key market trends and opportunities

4.2.8.2.Market size and forecast

4.2.9.Weight monitoring devices

4.2.9.1.Key market trends and opportunities

4.2.9.2.Market size and forecast

4.2.10.Temperature monitoring devices

4.2.10.1.Key market trends and opportunities

4.2.10.2.Market size and forecast

4.2.11.Urine output monitoring

4.2.11.1.Key market trends and opportunities

4.2.11.2.Market size and forecast

4.3.Service

4.3.1.Market size and forecast

4.3.2.Consulting

4.3.2.1.Market size and forecast

4.3.3.System Integration and Deployment

4.3.3.1.Market size and forecast

4.3.4.Support and Maintenance

4.3.4.1.Market size and forecast

4.4.Connectivity Technology

4.4.1.Cellular IoT - 3G

4.4.1.1.Market size and forecast

4.4.2.Cellular IoT - 4G

4.4.2.1.Market size and forecast

4.4.3.Wi-Fi

4.4.3.1.Market size and forecast

4.4.4.SIGFOX

4.4.4.1.Market size and forecast

4.4.5.Wireline

4.4.5.1.Market size and forecast

4.4.6.Wireless Personal Area Network (WPAN)

4.4.6.1.Market size and forecast

4.4.7.Others

4.4.7.1.Market size and forecast

5.1.ABBOTT LABORATORIES

5.1.1.Company overview

5.1.2.Company snapshot

5.1.3.Operating business segments

5.1.4.Product portfolio

5.1.5.Business performance

5.1.6.Key strategic moves and developments

5.2.BIOTRONIK SE & CO. KG

5.2.1.Company overview

5.2.2.Company snapshot

5.2.3.Operating business segments

5.2.4.Product portfolio

5.2.5.Key strategic moves and developments

5.3.BOSTON SCIENTIFIC CORPORATION

5.3.1.Company overview

5.3.2.Company snapshot

5.3.3.Operating business segments

5.3.4.Product portfolio

5.3.5.Business performance

5.3.6.Key strategic moves and developments

5.4.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

5.4.1.Company overview

5.4.2.Company snapshot

5.4.3.Operating business segments

5.4.4.Product portfolio

5.4.5.Business performance

5.4.6.Key strategic moves and developments

5.5.F. HOFFMANN-LA ROCHE LTD.

5.5.1.Company overview

5.5.2.Company snapshot

5.5.3.Operating business segments

5.5.4.Product portfolio

5.5.5.Business performance

5.5.6.Key strategic moves and developments

5.6.KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

5.6.1.Company overview

5.6.2.Company snapshot

5.6.3.Operating business segments

5.6.4.Product portfolio

5.6.5.Business performance

5.6.6.Key strategic moves and developments

5.7.MASIMO CORPORATION

5.7.1.Company overview

5.7.2.Company snapshot

5.7.3.Product portfolio

5.7.4.Business performance

5.7.5.Key Strategic Moves and Developments

5.8.MEDTRONIC PLC.

5.8.1.Company overview

5.8.2.Company snapshot

5.8.3.Operating business segments

5.8.4.Medtronic offers following patient monitoring devices

5.8.5.Business performance

5.8.6.Key strategic moves and developments

5.9.NIHON KOHDEN CORPORATION

5.9.1.Company overview

5.9.2.Company snapshot

5.9.3.Operating business segments

5.9.4.Product portfolio

5.9.5.Business performance

5.9.6.Key strategic moves and developments

5.10.OSI Systems, Inc. (Spacelabs Healthcare)

5.10.1.Company overview

5.10.2.Company snapshot

5.10.3.Operating business segments

5.10.4.Product portfolio

5.10.5.Business performance

5.10.6.Key Strategic Moves and Developmen

LIST OF TABLES

TABLE 01.CLINICAL TRIALS: PATIENT MONITORING SYSTEMS MARKET, 2013–2020

TABLE 02.PATENTS REGISTERED/APPROVED ACROSS THE GLOBE, 2011–2020

TABLE 03.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011–2020

TABLE 04.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011- 2020

TABLE 05.U.S. PATIENT MONITORING SYSTEMS MARKET, BY COMPONENT, 2019–2027 ($MILLION)

TABLE 06.U.S. PATIENT MONITORING SYSTEMS MARKET, BY DEVICE TYPE, 2019–2027 ($MILLION)

TABLE 07.U.S. PATIENT MONITORING SYSTEMS MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 08.ABBOTT: COMPANY SNAPSHOT

TABLE 09.ABBOTT: OERATING SEGMENT

TABLE 10.ABBOTT: PRODUCT PORTFOLIO

TABLE 11.BIOTRONIK: COMPANY SNAPSHOT

TABLE 12.BIOTRONIK: OPERATING SEGMENTS

TABLE 13.BIOTRONIK: PRODUCT PORTFOLIO

TABLE 14.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 15.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS

TABLE 16.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 17.GE: COMPANY SNAPSHOT

TABLE 18.GE: OPERATING SEGMENTS

TABLE 19.GE: PRODUCT PORTFOLIO

TABLE 20.ROCHE: COMPANY SNAPSHOT

TABLE 21.ROCHE: OERATING SEGMENT

TABLE 22.ROCHE: PRODUCT PORTFOLIO

TABLE 23.PHILIPS: COMPANY SNAPSHOT

TABLE 24.PHILIPS: OPERATING SEGMENTS

TABLE 25.PHILIPS: PRODUCT PORTFOLIO

TABLE 26.MASIMO: COMPANY SNAPSHOT

TABLE 27.MASIMO: PRODUCT PORTFOLIO

TABLE 28.MEDTRONIC: COMPANY SNAPSHOT

TABLE 29.MEDTRONIC: OPERATING BUSINESS SEGMENTS

TABLE 30.MEDTRONIC: PRODUCT PORTFOLIO

TABLE 31.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 32.NIHON KOHDEN: PRODUCT PORTFOLIO

TABLE 33.OSI SYSTEMS: COMPANY SNAPSHOT

TABLE 34.OSI SYSTEMS: OPERATING SEGMENTS

TABLE 35.OSI SYSTEMS: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01.TOP INVESTMENT POCKETS: U.S. PATIENT MONITORING SYSTEMS MARKET, BY DEVICE TYPE

FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2017–2020*

FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020* (%)

FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020* (%)

FIGURE 05.TOP PLAYER POSITIONING

FIGURE 06.MODERATE BARGAINING POWER OF BUYERS

FIGURE 07.HIGH BARGAINING POWER OF SUPPLIERS

FIGURE 08.HIGH THREAT OF NEW ENTRANTS

FIGURE 09.MODERATE THREAT OF SUBSTITUTION

FIGURE 10.HIGH COMPETITIVE RIVALRY

FIGURE 11.PATENTS REGISTERED/APPROVED, 2011–2020

FIGURE 12.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011–2020

FIGURE 13.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020

FIGURE 14.HEMODYNAMIC MONITORING DEVICES MARKET, 2019-2027

FIGURE 15.NEUROMONITORING DEVICE MARKET, 2019-2027

FIGURE 16.CARDIAC MONITORING DEVICES MARKET, 2019-2027

FIGURE 17.FETAL AND NEONATAL MONITORING DEVICES MARKET, 2019-2027

FIGURE 18.RESPIRATORY MONITORS MARKET, 2019-2027

FIGURE 19.MULTIPARAMETER MONITORING DEVICES MARKET, 2019-2027

FIGURE 20.REMOTE PATIENT MONITORING DEVICES MARKET, 2019-2027

FIGURE 21.WEIGHT MONITORING DEVICES MARKET, 2019-2027

FIGURE 22.TEMPERATURE MONITORING DEVICES MARKET, 2019-2027

FIGURE 23.URINE OUTPUT MONITORING DEVICES MARKET, 2019-2027

FIGURE 24.PATIENT MONITORING SYSTEMS MARKET FOR CONSULTING, 2019-2027

FIGURE 25.PATIENT MONITORING SYSTEMS MARKET FOR SYSTEM INTEGRATION AND DEPLOYMENT, 2019-2027

FIGURE 26.PATIENT MONITORING SYSTEMS MARKET FOR SUPPORT AND MAINTENANCE, 2019-2027

FIGURE 27.PATIENT MONITORING SYSTEMS MARKET FOR CELLULAR IOT - 3G, 2019-2027

FIGURE 28.PATIENT MONITORING SYSTEMS MARKET FOR CELLULAR IOT - 4G, 2019-2027

FIGURE 29.PATIENT MONITORING SYSTEMS MARKET FOR WI-FI, 2019-2027

FIGURE 30.PATIENT MONITORING SYSTEMS MARKET FOR SIGFOX, 2019-2027

FIGURE 31.PATIENT MONITORING SYSTEMS MARKET FOR WIRELINE, 2019-2027

FIGURE 32.PATIENT MONITORING SYSTEMS MARKET FOR WIRELESS PERSONAL AREA NETWORK (WPAN), 2019-2027

FIGURE 33.PATIENT MONITORING SYSTEMS MARKET FOR OTHERS, 2019-2027

FIGURE 34.ABBOTT: NET SALES, 2017–2019 ($MILLION)

FIGURE 35.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 36.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)

FIGURE 37.BOSTON SCIENTIFIC CORPORATION: NET SALES, 2017–2019 ($MILLION)

FIGURE 38.BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 39.BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2019 (%)

FIGURE 40.GE: NET SALES, 2017–2019 ($MILLION)

FIGURE 41.GE: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 42.GE: REVENUE SHARE, BY REGION, 2019 (%)

FIGURE 43.ROCHE: NET SALES, 2017–2019 ($MILLION)

FIGURE 44.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 45.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)

FIGURE 46.PHILIPS: NET SALES, 2017–2019 ($MILLION)

FIGURE 47.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 48.PHILIPS: REVENUE SHARE, BY REGION, 2019(%)

FIGURE 49.MASIMO: NET SALES, 2017-2019 ($MILLION)

FIGURE 50.MASIMO: REVENUE SHARE, BY REGION, 2019 (%)

FIGURE 51.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)

FIGURE 52.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 53.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)

FIGURE 54.NIHON KOHDEN: NET SALES, 2016–2018 ($MILLION)

FIGURE 55.NIHON KOHDEN: REVENUE SHARE, BY PRODUCT SEGMENT, 2018 (%)

FIGURE 56.NIHON KOHDEN: REVENUE SHARE, BY REGION, 2018 (%)

FIGURE 57.OSI SYSTEMS: NET SALES, 2016–2018 ($MILLION)

FIGURE 58.OSI SYSTEMS: REVENUE SHARE, BY SEGMENT, 2018 (%)

FIGURE 59.OSI SYSTEMS: REVENUE SHARE, BY REGION, 2018 (%